Biogen Inc. (ETR:IDP)
Germany · Delayed Price · Currency is EUR 126.10
-3.45 (-2.66%)
Oct 10, 2025, 5:35 PM CET
Biogen Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Net Income | 1,531 | 1,632 | 1,162 | 2,962 | 1,728 | 4,061 | Upgrade |
Depreciation & Amortization | 744.3 | 673.2 | 494.8 | 518.4 | 487.7 | 457.2 | Upgrade |
Stock-Based Compensation | 303.7 | 291.2 | 264.2 | 254.1 | 238.6 | 198.3 | Upgrade |
Other Adjustments | 335.5 | 434.1 | 275.4 | -1,460 | 1,332 | -299 | Upgrade |
Change in Receivables | 30.7 | 194.2 | 56.7 | -222.4 | 326 | 179.5 | Upgrade |
Changes in Inventories | -113.5 | -273.8 | -130.9 | -320.2 | -462.4 | -316.3 | Upgrade |
Changes in Accrued Expenses | -178.5 | 24.6 | -201.6 | -113.4 | -95.4 | 154.2 | Upgrade |
Changes in Income Taxes Payable | -448.5 | 78.5 | -299 | -142.3 | 230.8 | -67.5 | Upgrade |
Changes in Other Operating Activities | -151.2 | -178.7 | -73.9 | -92 | -144.5 | -137.1 | Upgrade |
Operating Cash Flow | 2,117 | 2,876 | 1,547 | 1,384 | 3,640 | 4,230 | Upgrade |
Operating Cash Flow Growth | 18.66% | 85.85% | 11.77% | -61.97% | -13.95% | -40.24% | Upgrade |
Capital Expenditures | -138 | -153.7 | -277 | -240.3 | -258.1 | -424.8 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | 582.6 | 93.5 | - | Upgrade |
Purchases of Intangible Assets | - | -206.1 | -34.4 | -2.9 | -36.8 | -127 | Upgrade |
Proceeds from Sale of Intangible Assets | - | 88.6 | - | - | - | - | Upgrade |
Purchases of Investments | - | - | -5,141 | -3,449 | -3,809 | -7,404 | Upgrade |
Proceeds from Sale of Investments | - | 144.7 | 8,289 | 4,661 | 3,405 | 7,374 | Upgrade |
Payments for Business Acquisitions | - | -668 | -6,926 | - | - | - | Upgrade |
Proceeds from Business Divestments | - | - | 788.1 | 990.3 | 28.1 | - | Upgrade |
Other Investing Activities | -32 | 83.9 | -11.3 | 24.4 | -5.1 | -101.9 | Upgrade |
Investing Cash Flow | -1,304 | -799.2 | -4,101 | 1,577 | -563.7 | -608.6 | Upgrade |
Long-Term Debt Issued | - | - | 997.2 | - | - | 2,967 | Upgrade |
Long-Term Debt Repaid | - | -650 | -809.9 | -1,002 | -170 | -1,500 | Upgrade |
Net Long-Term Debt Issued (Repaid) | - | -650 | 187.3 | -1,002 | -170 | 1,467 | Upgrade |
Repurchase of Common Stock | - | - | - | -750 | -1,800 | -6,679 | Upgrade |
Net Common Stock Issued (Repurchased) | - | - | - | -750 | -1,800 | -6,679 | Upgrade |
Other Financing Activities | -16.8 | -33.5 | -38 | 4.9 | -116.2 | -61 | Upgrade |
Financing Cash Flow | -33.4 | -683.5 | 149.3 | -1,747 | -2,086 | -5,273 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 70.6 | -67.7 | 35.1 | -55.7 | -59.8 | 69 | Upgrade |
Net Cash Flow | 779.3 | 1,393 | -2,405 | 1,214 | 990 | -1,652 | Upgrade |
Beginning Cash & Cash Equivalents | 1,909 | 1,050 | 3,419 | 2,261 | 1,331 | 2,914 | Upgrade |
Ending Cash & Cash Equivalents | 2,759 | 2,375 | 1,050 | 3,419 | 2,261 | 1,331 | Upgrade |
Free Cash Flow | 1,979 | 2,722 | 1,270 | 1,144 | 3,382 | 3,805 | Upgrade |
Free Cash Flow Growth | -27.30% | 114.28% | 11.03% | -66.17% | -11.12% | -42.03% | Upgrade |
FCF Margin | 20.06% | 28.13% | 12.91% | 11.25% | 30.79% | 28.30% | Upgrade |
Free Cash Flow Per Share | 13.53 | 18.66 | 8.72 | 7.84 | 22.61 | 23.59 | Upgrade |
Levered Free Cash Flow | 1,245 | 1,152 | 860.8 | 1,658 | 1,179 | 5,139 | Upgrade |
Unlevered Free Cash Flow | 1,569 | 2,097 | 956.48 | 2,480 | 2,513 | 3,321 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.